Researcher.Life Logo

Innovative Medicine of Kuban : Impact Factor & More

eISSN: 2541-9897pISSN: 2500-0268
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Innovative Medicine of Kuban Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Scientific Research Institute — Ochapovsky Clinical Regional Hospital no. 1
Language Russian
Publication Time6
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian
Society/Institute/SponsorScientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicyCopyright Notice
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Innovative Medicine of Kuban ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Innovative Medicine of Kuban

Design Features of Nonclinical Studies for In Vivo Gene Therapy Medicinal Products. Part 2: Pharmacokinetic and Toxicological Studies
  • 1 Mar 2026
  • Innovative Medicine of Kuban
Thyroidectomy and Lymph Node Dissection for Highly Differentiated Thyroid Cancer Using a New Cervical Approach: A Clinical Case
  • 1 Mar 2026
  • Innovative Medicine of Kuban
A Clinical Case of Palliative Care during the Progression of a Patient with Advanced Lung Cancer Undergoing Gefitinib Therapy and Subsequent Transition to Osimertinib: The Role of Palliative Care in Oncology
  • 1 Mar 2026
  • Innovative Medicine of Kuban
Rupture of a Middle Cerebral Artery Aneurysm 11 Years After Diagnosis Verification
  • 1 Mar 2026
  • Innovative Medicine of Kuban
Selection of the Optimal Femoropopliteal Bypass Strategy According to Autologous Vein Availability and Graft Thrombosis Risk
  • 29 Nov 2025
  • Innovative Medicine of Kuban
Exosome-Based Therapies for Scar-Free Skin Regeneration: Clinical Applications and Emerging Trends
  • 29 Nov 2025
  • Innovative Medicine of Kuban
Design Features of Nonclinical Studies for In Vivo Gene Therapy Medicinal Products. Part 2: Pharmacokinetic and Toxicological Studies
  • 1 Mar 2026
  • Innovative Medicine of Kuban
Thyroidectomy and Lymph Node Dissection for Highly Differentiated Thyroid Cancer Using a New Cervical Approach: A Clinical Case
  • 1 Mar 2026
  • Innovative Medicine of Kuban
A Clinical Case of Palliative Care during the Progression of a Patient with Advanced Lung Cancer Undergoing Gefitinib Therapy and Subsequent Transition to Osimertinib: The Role of Palliative Care in Oncology
  • 1 Mar 2026
  • Innovative Medicine of Kuban
Rupture of a Middle Cerebral Artery Aneurysm 11 Years After Diagnosis Verification
  • 1 Mar 2026
  • Innovative Medicine of Kuban
Selection of the Optimal Femoropopliteal Bypass Strategy According to Autologous Vein Availability and Graft Thrombosis Risk
  • 29 Nov 2025
  • Innovative Medicine of Kuban
Exosome-Based Therapies for Scar-Free Skin Regeneration: Clinical Applications and Emerging Trends
  • 29 Nov 2025
  • Innovative Medicine of Kuban

FAQs on Innovative Medicine of Kuban